GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Etao International Co Ltd (OTCPK:ETAOF) » Definitions » EV-to-EBITDA

Etao International Co (Etao International Co) EV-to-EBITDA : -0.00 (As of May. 26, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Etao International Co EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Etao International Co's enterprise value is $2.64 Mil. Etao International Co's EBITDA for the trailing twelve months (TTM) ended in Jun. 2023 was $-895.55 Mil. Therefore, Etao International Co's EV-to-EBITDA for today is -0.00.

The historical rank and industry rank for Etao International Co's EV-to-EBITDA or its related term are showing as below:

During the past 2 years, the highest EV-to-EBITDA of Etao International Co was -0.01. The lowest was -0.41. And the median was -0.04.

ETAOF's EV-to-EBITDA is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 12.715
* Ranked among companies with meaningful EV-to-EBITDA only.

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-26), Etao International Co's stock price is $0.30. Etao International Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was $-169.606. Therefore, Etao International Co's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Etao International Co EV-to-EBITDA Historical Data

The historical data trend for Etao International Co's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Etao International Co EV-to-EBITDA Chart

Etao International Co Annual Data
Trend Dec21 Dec22
EV-to-EBITDA
- -

Etao International Co Quarterly Data
Sep21 Dec21 Jun22 Sep22 Dec22 Jun23
EV-to-EBITDA Get a 7-Day Free Trial - - - - -0.08

Competitive Comparison of Etao International Co's EV-to-EBITDA

For the Health Information Services subindustry, Etao International Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Etao International Co's EV-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Etao International Co's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Etao International Co's EV-to-EBITDA falls into.



Etao International Co EV-to-EBITDA Calculation

Etao International Co's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=2.642/-895.551
=-0.00

Etao International Co's current Enterprise Value is $2.64 Mil.
Etao International Co's EBITDA for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-895.55 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Etao International Co  (OTCPK:ETAOF) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Etao International Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.30/-169.606
=At Loss

Etao International Co's share price for today is $0.30.
Etao International Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-169.606.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Etao International Co EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Etao International Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Etao International Co (Etao International Co) Business Description

Traded in Other Exchanges
N/A
Address
1460 Broadway, 14th Floor, New York, NY, USA, 10036
Etao International Co Ltd is a digital healthcare group providing medical care and biomedical technologies to patients in China. It provides a comprehensive healthcare service consisting of both online and offline capabilities. These services include online health insurance and pharmacy, digital diabetes management, and biotech. Offline healthcare services include hospital and specialty clinics, such as infertility, orthopedic surgery, plastic surgery, and primary care.